If an individual has exhausted all standard treatment options for a medical condition and there is enough evidence that medicinal cannabis may help them achieve better health outcomes, then their doctor may be able to obtain approval for treatment with medicinal cannabis.1
Currently there are three pathways to accessing Medicinal Cannaibis in Australia. These are:
Special Access Scheme:
The Therapeutic Goods Administration (TGA) Special Access Scheme (SAS) supports patients in accessing unapproved medicines in Australia that and for some patients, the state health authority must approve each individual prescription for unapproved medicinal cannabis.1
Generally, the process for approval follows these steps, with minor differences between states and territories:1,2
Step 1 – Patient consults with doctor
A through clinical assessment with a doctor is necessary to determine if medicinal cannabis is appropriate for a patient’s conditional and individual circumstances. All medical doctors, including a patient’s regular GP, may undertake the assessment. Some doctors, however, may choose to share the patient’s care (‘shared-care’) with a doctor that is experienced with medicinal cannabis prescribing. There are a number of shared-care clinics in Australia that specialise in medicinal cannabis prescribing. Patients can also find a doctor here.
Step 2 – Doctor applies for approval
Approval required from the TGA (under the Special Access Scheme) and in some special cases, the local health authority. The doctor may choose to apply for approval themselves or refer to a doctor who specialises in prescribing medicinal cannabis.
Step 3 – Doctor provides prescription
Following approval, a doctor may prescribe a medicinal cannabis product for that individual patient. The doctor will arrange supply with a pharmacy that is convenient for the patient.
Step 4 – Prescription dispensed from a pharmacy
Pharmacies can order the product only once the prescription and TGA-approval is received as it is illegal for pharmacies to hold stock of unapproved medicinal cannabis medicines.
A medical doctor may be granted authority by the TGA to become an ‘Authorised Prescriber’ of a specified unapproved therapeutic good to specific patients (or classes of recipients) with a particular medical condition.
Individuals may be eligible to participate in medicinal cannabis clinical trials. Clinical trials conducted in Australia are subject to various regulatory controls to ensure the safety of participants.
At present we are not recruiting for our Australian Clinical research.
An observational study will commence shortly for patients prescribed Bod Pharmaceuticals Medical Cannabis. The normal cost of the medicine and practitioner consultation applies for observational trials.
Register your interest for clinical trials here.
For further information contact us or go to: https://www.tga.gov.au/access-medicinal-cannabis-products-1